Cell Guidance Systems is based in Cambridge, UK. We were founded in 2010 and opened our US office in 2011. Over the years, we have been quietly building a reputation for quality, service and innovation. We are part of one of the most exciting biotech regions in the world. We work to bring innovations from research groups around the world (including Japan, USA, Netherlands, Italy, Singapore and the UK) to develop products that expand the possibilities of life science research. Many of our products are truly groundbreaking: For example, ETS-embryo medium (developed in the lab of Prof Magdalena Zernicka-Goetz at Cambridge University) enables the production of artificial embryos from stem cells. PODS™ (developed in the lab of Prof Hajime Mori at Kyoto Institute of Technology) is overcoming stability limitations of proteins, offering hope for new therapies.

Our innovative products include: 

In addition, we supply:

We also offer a range of cost-effective services:

In addition to providing reagents and research services, we are involved in several areas of therapeutic research based on the PODS™ technology. We are collaborating with researchers and companies in the UK, Italy and Japan to develop vaccines and therapeutics for a variety of diseases. More details are given in our technology and news pages.

The pursuit of quality drives everything we do, from the components we use, the manufacturing process and the final preparation and packaging of the product. We employ rigorous quality control to ensure products function effectively. 

Research is often expensive and budgets limited. We understand the importance of offering value for money across our product range. Timely and effective communication with our customers is important to us. We strive for the highest levels of service in all our interactions with customers and in our business dealings. 

We're here to help you on your quest to discover the unknown, understand the complex, and heal the many diseases and conditions that affect us all.